Menu ×

HEALTHCARE & PHARMACEUTICAL

Starch Capsule Market Segmentation By Application (Health Supplements, Cardiovascular Drugs, Sedatives, Analgesics and Others) and By End User (Pharmaceuticals, Nutraceuticals and Cosmetics) - Global Industry Demand Analysis and Opportunity Assessment 2019-2028

  • Text Size:

Extensive insights into the Growth of Starch Capsule Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More
IN THE NEWS
  • May 2019: Lonza announced the launch of its new product Vcaps Plus White Opal capsule in order to meet the demand for opaque capsules that are titanium-free.
  • December 2019: Lonza announced that it has acquired the leading oral drug delivery technology company, Capsugel. The acquisition is anticipated to enable Lonza to expand its product portfolio.

Market Overview

The growth of the global starch capsule market is thriving on the back of the rapidly increasing use of starch capsules in the pharmaceutical as well as nutraceutical sector. Additionally, the increasing healthcare expenditure in various countries across the world is also expected to drive the growth of the market. Furthermore, it has also been observed that the capsule that are made with starch possess higher burst strength and elasticity which is also projected to fuel up the growth of the market in various regions across the world.

The global starch capsule market reached USD 354.45 million in the year 2019 and is expected to garner USD 869.69 million by the end of 2028 by registering a CAGR of 10.64% across the globe over the forecast period 2021-2028. On the other hand, the market is anticipated to gain an incremental $ opportunity of USD 35.09 million in the year 2020 as compared to the previous year. Moreover, the market is also expected to grow by 2.03x and further gain an absolute $ opportunity of USD 441.16 million during the forecast period.

Growth Highlights based on Region during 2019-2028

The global starch capsule market is segmented by regions into North America, Latin America, Europe, Asia Pacific and Middle East and Africa. It is to be noted that in the global market, countries such as US, Germany, China, UK & Japan are presently capturing the largest markets with China expected to grow at the highest rate. Various factors such as rising awareness among people regarding nutritional deficiencies, immune deficiencies, rising geriatric population, rising incidences of various disorders along with favorably changing regulatory landscape is expected to result in a rise in demand for starch capsules in the global market.

The study further incorporates Y-O-Y Growth, demand & supply and forecast future opportunity in North America (United States, Canada), Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX [Belgium, Netherlands, Luxembourg], NORDIC [Norway, Denmark, Sweden, Finland], Poland, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).  CLICK TO DOWNLOAD SAMPLE

Market Segmentation Synopsis

By Application

The global starch capsule market has been segmented by application into health supplements, cardiovascular drugs, sedatives, analgesics and others. Over the recent years, it has been observed that there is an increasing number of people preferring dietary supplements to address various nutritional deficiencies or as immunity boosters. This is resulting in a rise in demand for capsules to accommodate the consumer driven requirement. Moreover, the shifting preferences of people towards the vegetarian capsules instead of hard-shell gelatin capsule is expected to impact the market positively. The starch capsules are considered as an ideal alternative for hard gelatin capsules with no preservatives, gelatin, gluten and animal by products. This factor is further expected to raise the demand for the product among the health-conscious customers, thus accelerating the expansion of the market.

Market Drivers and Challenges

Growth Indicators

Numerous Benefits Associated with Starch Capsules

Starch capsules are known to possess several benefits. In the healthcare industry, the starch capsules are considered as a very efficient alternative delivery system for orally administered compound. On the other hand, the starch-based capsules are known for their cost-effectiveness, which has further created a shift in the preference of the customers, thus accelerating the growth of the market.

Increasing Advancements in the Healthcare Sector

Growing pharmaceutical spending by nations worldwide along with the increasing geriatric population worldwide is raising the need for advanced healthcare systems. Increasing spending for research and development has contributed to the development of advanced capsules, such as starch capsules, which is known to have several benefits. According to the status by Organisation for Economic Co-operation and Development (OECD), pharmaceutical spending in the United States increased from 1198 USD/capita in the year 2015 to 1220 USD/capita in the year 2017.

Starch-Capsule-Market

Barriers

High cost of production, lack of consumer awareness, changing production technologies and quality standards along with the fluctuating social and economic conditions and the government regulations are some of the factors anticipated to act as a barrier to the growth of the global starch capsule market during the forecast period.

Competitive Landscape

The global starch capsule market is driven by several affluent industry leaders, including players such as Lonza. On the other hand, numerous manufacturers in the pharmaceutical industry which manufacture different types of capsules, are increasingly investing on to develop and adapt new technologies for expanding their existing product portfolio.

FREQUENTLY ASKED QUESTIONS


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2020 Research Nester. All Rights Reserved